Boehringer Ingelheim and GST prepared bring innovation to equine market Boehringer Ingelheim and GST prepared bring innovation to equine market Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine market
Welcome to Innovation at Boehringer Ingelheim Welcome to Innovation at Boehringer Ingelheim Watch our video and find out more about innovation at Boehringer Ingelheim.
Boehringer Ingelheim Innovation Prize Boehringer Ingelheim Innovation Prize Find out more about how we’re providing valuable resources to life-science innovators to enable new and emerging science
Boehringer Ingelheim Innovation Prize Video 2023 Boehringer Ingelheim Innovation Prize Video 2023 Boehringer Ingelheim's Innovation Prize provides valuable resources to help early-stage companies progress their science.
How Boehringer Ingelheim is Supporting Grass Roots Innovation How Boehringer Ingelheim is Supporting Grass Roots Innovation Our Grass Roots activities support life-science innovators with mentoring and networking opportunities.
collaboration criving innovation collaboration criving innovation In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
Boehringer Olaf Scholz break ground for innovation center Boehringer Olaf Scholz break ground for innovation center Boehringer Ingelheim and German Chancellor Olaf Scholz lay the foundation stone for 285 million EUR innovation center
Open Innovation at Boehringer Ingelheim Open Innovation at Boehringer Ingelheim Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Collaboration Boehringer Ingelheim Veeva technology Collaboration Boehringer Ingelheim Veeva technology Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
Boehringer Ingelheim announces collaboration with MabGenesis Boehringer Ingelheim announces collaboration with MabGenesis Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
Boehringer Ingelheim invests in precision cancer treatments Boehringer Ingelheim invests in precision cancer treatments Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies
Boehringer Ingelheim attends WVPAC 2019 Boehringer Ingelheim attends WVPAC 2019 Boehringer Ingelheim attends and showcases its leading vaccines and services at 21st World Veterinary Poultry Association Congress
Monoclonal antibodies Boehringer Ingelheim and Invetx Monoclonal antibodies Boehringer Ingelheim and Invetx Boehringer Ingelheim and Invetx announce collaboration to discover, develop and commercialize novel veterinary monoclonal antibody biotherapeutics
Boehringer Ingelheim reaches more patients than ever, innovation drives growth Boehringer Ingelheim reaches more patients than ever, innovation drives growth Boehringer Ingelheim reports a strong performance in 2022.
Innovation and drone delivery Innovation and drone delivery Addressing healthcare disparities through collaborative innovation and drone delivery
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
BI increases commitments to sustainable development BI increases commitments to sustainable development At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development
Boehringer Ingelheim Second Transforming Science Day Boehringer Ingelheim Second Transforming Science Day World-renowned top scientists and companies in R&D take the stage at Boehringer Ingelheim’s second Transforming Science Day
Excellence in innovation | Bioxcellence | Boehringer Ingelheim Excellence in innovation | Bioxcellence | Boehringer Ingelheim Discover BioXcellence's commitment to innovation in pharmaceutical production, delivering cutting-edge solutions for your biopharmaceutical needs.
Boehringer Ingelheim Advances Oncology Research Boehringer Ingelheim Advances Oncology Research Boehringer Ingelheim Advances Its Oncology Research Program Through Innovative Partnerships
Boehringer Ingelheim acquires Nerio Therapeutics Boehringer Ingelheim acquires Nerio Therapeutics Today marks a significant step for Boehringer Ingelheim’s immuno-oncology pipeline by adding an innovative preclinical program with the acquisition of Nerio Therapeutics
Boehringer Ingelheim leader in hatchery vaccination Boehringer Ingelheim leader in hatchery vaccination Boehringer Ingelheim is a leader in hatchery vaccination with vector vaccines.
Social innovation: catalyst for sustainable health solutions Social innovation: catalyst for sustainable health solutions Supporting social innovators drives sustainable health solutions in underserved communities. Learn more about Boehringer Ingelheim Social Engagements.
Boehringer Ingelheim acquires a stake in SoundTalks Boehringer Ingelheim acquires a stake in SoundTalks Boehringer Ingelheim acquires stake in SoundTalks NV, begins pilot programme
Partnership Boehringer Ingelheim Lifebit health data Partnership Boehringer Ingelheim Lifebit health data Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data